Androgen receptor inhibitor-induced "BRCAness" and PARP inhibition are synthetically lethal for castration-resistant prostate cancer.

MLA

Li, Likun, et al. “Androgen Receptor Inhibitor-Induced ‘BRCAness’ and PARP Inhibition Are Synthetically Lethal for Castration-Resistant Prostate Cancer.” Science Signaling, vol. 10, no. 480, May 2017. EBSCOhost, https://doi.org/10.1126/scisignal.aam7479.

APA

Li, L., Karanika, S., Yang, G., Wang, J., Park, S., Broom, B. M., Manyam, G. C., Wu, W., Luo, Y., Basourakos, S., Song, J. H., Gallick, G. E., Karantanos, T., Korentzelos, D., Azad, A. K., Kim, J., Corn, P. G., Aparicio, A. M., Logothetis, C. J., … Thompson, T. C. (2017). Androgen receptor inhibitor-induced “BRCAness” and PARP inhibition are synthetically lethal for castration-resistant prostate cancer. Science Signaling, 10(480). https://doi.org/10.1126/scisignal.aam7479

Chicago

Li, Likun, Styliani Karanika, Guang Yang, Jiangxiang Wang, Sanghee Park, Bradley M Broom, Ganiraju C Manyam, et al. 2017. “Androgen Receptor Inhibitor-Induced ‘BRCAness’ and PARP Inhibition Are Synthetically Lethal for Castration-Resistant Prostate Cancer.” Science Signaling 10 (480). doi:10.1126/scisignal.aam7479.